ArticleBMC gastroenterology2019

Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women.

Jinsong Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.